RU2005138922A - METHOD FOR DAABUL PREVENTION AND TREATMENT OF ONCOLOGICAL DISEASES - Google Patents
METHOD FOR DAABUL PREVENTION AND TREATMENT OF ONCOLOGICAL DISEASES Download PDFInfo
- Publication number
- RU2005138922A RU2005138922A RU2005138922/14A RU2005138922A RU2005138922A RU 2005138922 A RU2005138922 A RU 2005138922A RU 2005138922/14 A RU2005138922/14 A RU 2005138922/14A RU 2005138922 A RU2005138922 A RU 2005138922A RU 2005138922 A RU2005138922 A RU 2005138922A
- Authority
- RU
- Russia
- Prior art keywords
- prevention
- treatment
- daabul
- oncological diseases
- dose
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2005138922/14A RU2317820C2 (en) | 2005-12-14 | 2005-12-14 | Daabul's method for normalization and stabilization of macrophage homeostasis in treatment of oncological diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2005138922/14A RU2317820C2 (en) | 2005-12-14 | 2005-12-14 | Daabul's method for normalization and stabilization of macrophage homeostasis in treatment of oncological diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2005138922A true RU2005138922A (en) | 2007-06-20 |
RU2317820C2 RU2317820C2 (en) | 2008-02-27 |
Family
ID=38314065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2005138922/14A RU2317820C2 (en) | 2005-12-14 | 2005-12-14 | Daabul's method for normalization and stabilization of macrophage homeostasis in treatment of oncological diseases |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2317820C2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2629338C1 (en) * | 2016-08-26 | 2017-08-28 | Алам Джан | Pharmaceutical composition for homeostasis stabilization and pathological processes arresting in organism, and injection dosage form of this composition |
WO2023048596A1 (en) * | 2021-09-22 | 2023-03-30 | Владислав Николаевич ЛАСКАВЫЙ | Composition for maintaining a normal state of homeostasis and drug based thereon |
-
2005
- 2005-12-14 RU RU2005138922/14A patent/RU2317820C2/en active IP Right Revival
Also Published As
Publication number | Publication date |
---|---|
RU2317820C2 (en) | 2008-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR050418A1 (en) | HER ANTIBODY FIXED DOSAGE | |
JP2006504723A5 (en) | ||
AR124500A2 (en) | INCREASED BIOAVAILABILITY OF THE DRUG IN NALTREXONE THERAPY | |
EA200802412A1 (en) | THERAPEUTIC COMBINATIONS FOR SUPPORTING MEDICAL CONDITIONS | |
MA34547B1 (en) | ASSOCIATION TREATMENT FOR TREATING HCV INFECTION | |
TW200740424A (en) | Taste masking dosage form | |
EA200800075A1 (en) | DOSING CIRCUIT FOR WISE | |
WO2008045378A3 (en) | Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin | |
JP2006514116A5 (en) | ||
RU2007105500A (en) | LIVER CANCER APPEARANCE AND DEVELOPMENT INHIBITOR FOR USE IN HUMAN PATIENTS WITH LIVER CIRROSIS POSITIVE FOR HEPATITIS C VIRUS | |
RU2005138922A (en) | METHOD FOR DAABUL PREVENTION AND TREATMENT OF ONCOLOGICAL DISEASES | |
IL170519A (en) | Use of fenofibrate or pharmaceutically acceptable salt thereof, orlistat and pharmaceutically acceptable carrier in the manufacture of medicaments for the treatment of obesity and pharmaceutical compositions containing them | |
CL2007001864A1 (en) | UNIT DOSE FORM OF TEMOZOLOMIDE INCLUDING TEMOZOLOMIDE AND A PHARMACEUTICALLY ACCEPTABLE CARRIER; USES OF SUCH DOSAGE FORM TO TREAT A PATIENT WITH GLIOMA OR VARIOUS TYPES OF CANCER. | |
RU2005102282A (en) | METHOD FOR TREATMENT OF ANXIETY-DEPRESSIVE DISORDERS AND VEGETATIVE IMBALANCE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION | |
DK1399141T3 (en) | Use of acetyl L-carnitine for the manufacture of a medicament for the prevention of post-surgical pain | |
RU2005121068A (en) | METHOD OF PHYSICAL AND BIOLOGICAL PREVENTION OF ACUTE RADIATING DISEASE | |
RU2003110183A (en) | METHOD FOR TREATING MULTIPLE SCLEROSIS | |
RU2004132798A (en) | METHOD FOR PREVENTION AND TREATMENT OF FETOPLACENTAL INSUFFICIENCY | |
RU2008137014A (en) | METHOD FOR CORRECTION OF PSYCHIC-VEGATIVE DISORDERS IN PATIENTS WITH GALLSTONE DISEASE AFTER CHOLECYSTECTOMY | |
EA201170414A1 (en) | METHODS OF TREATING VASOMOTOR SYMPTOMS IN CASTERED PATIENTS WITH PROSTATE CANCER, LOW DOSES OF CYPROTERONE ACETATE | |
RU2002134891A (en) | MEDICINAL PRODUCT AND METHOD FOR TREATMENT OF GENITAL ACUTE-FINAL CONDILOMATOSIS | |
MD3446G2 (en) | Method of HIV infection treatment | |
RU2004132289A (en) | MEANS FOR TREATMENT OF INFECTIOUS DISEASES AND METHOD OF TREATMENT | |
NO20060045L (en) | Indole derivatives with apoptosis-inducing effect | |
RU2002124725A (en) | METHOD FOR TREATING PANCREATITIS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
QB4A | Licence on use of patent |
Effective date: 20080916 |
|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20081215 |
|
NF4A | Reinstatement of patent |
Effective date: 20110210 |